title: [Atrial fibrillation: novel possibilities of anticoagulant therapy in patients subjected to cardioversion].
authors: O V
authors: OV
authors: Averkov
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D001562:Benzimidazoles / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D000069604:Dabigatran; D016903:Drug Monitoring / Q000379:methods / Q000592:standards; D019560:Echocardiography, Three-Dimensional; D004554:Electric Countershock / Q000009:adverse effects*; D006801:Humans; D019934:International Normalized Ratio; D011292:Premedication / Q000379:methods / Q000592:standards; D016032:Randomized Controlled Trials as Topic; D020379:Risk Adjustment; D013923:Thromboembolism / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control*; D013997:Time Factors; D014859:Warfarin / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D015091:beta-Alanine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics
chemical_list: D000925:Anticoagulants; D001562:Benzimidazoles; D015091:beta-Alanine; D014859:Warfarin; D000069604:Dabigatran